StonvexLoading…
StonvexStonvexStonvexCore line items from AFRM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.06B | $721.89M | $320.48M | $1.11B |
Operating Income | $269.72M | $181.29M | $63.66M | $-87.27M |
Net Income | $313.18M | $129.59M | $80.69M | $52.19M |
EPS (Diluted) | $0.90 | $0.60 | $0.23 | $0.15 |
Total Assets | $13.14B | $12.96B | $11.48B | $11.15B |
Total Liabilities | $9.36B | $9.41B | $8.18B | $8.09B |
Cash & Equivalents | $1.72B | $1.53B | $1.43B | $1.35B |
Free Cash Flow OCF − CapEx | $763.34M | $438.24M | $320.21M | $601.72M |
Shares Outstanding | 348.56M | 348.82M | 348.28M | 341.02M |